Acceptability, adherence, and clinical outcomes, of amoxicillin dispersible tablets versus oral suspension in treatment of children aged 2–59 Months with pneumonia, Kenya: A cluster randomized controlled trial

Amoxicillin dispersible tablet (DT) is now recommended by the WHO as a first-line drug for the treatment of pneumonia in children below 5 years. The study aim was to compare acceptability, adherence and clinical outcome of amoxicillin DT and amoxicillin oral suspension (OS) in the treatment of child...

Descripción completa

Detalles Bibliográficos
Autores principales: Angwa, Linet M., Ouma, Collins, Okoth, Peter, Nyamai, Rachel, Kamau, Nyawira G., Mutai, Kennedy, Onono, Maricianah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160563/
https://www.ncbi.nlm.nih.gov/pubmed/32322742
http://dx.doi.org/10.1016/j.heliyon.2020.e03786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160563/
https://www.ncbi.nlm.nih.gov/pubmed/32322742
http://dx.doi.org/10.1016/j.heliyon.2020.e03786

Ejemplares similares